U.S. Physical Therapy (DB:UPH) - Cotización, noticias y análisis

Resumen de acción UPH

U.S. Physical Therapy, Inc. gestiona clínicas de fisioterapia ambulatoria. Saber más

Análisis fundamental de UPH
Puntuación del snowflake
Valoración	2/6
Crecimiento futuro	4/6
Rendimiento pasado	0/6
Salud financiera	4/6
Dividendos	3/6

Recompensas

Cotiza un 45.7% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 29.37%

Análisis de riesgos

Grandes partidas extraordinarias que afectan a los resultados financieros

Los márgenes de beneficio (2.2%) son inferiores a los del año pasado (4.1%)

El dividendo de 1.8% no está bien cubierto por los beneficios

Venta significativa por parte de personas con información privilegiada en los últimos 3 meses

Competidores de U.S. Physical Therapy, Inc.

RHÖN-KLINIKUM

XTRA:RHK

€836.7m

M1 Kliniken

XTRA:M12

€307.1m

LIMES Schlosskliniken

XTRA:LIK

€99.7m

Gesundheitswelt Chiemgau

MUN:JTH

€24.4m

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de U.S. Physical Therapy
Precios históricos de las acciones
Precio actual de la acción	US$89.50
Máximo en las últimas 52 semanas	US$104.00
Mínimo de 52 semanas	US$69.50
Beta	1.39
1Cambio en 1 mes	19.33%
Variación en 3 meses	20.13%
Cambio de 1 año	11.88%
3Variación en 3 años	13.29%
Variación en 5 años	-15.57%
Variación desde la OPV	590.59%

Noticias y actualizaciones recientes

Recent updates

Rentabilidad de los accionistas

	UPH	DE Healthcare	Mercado DE
7D	7.2%	1.1%	0.2%
1Y	11.9%	16.5%	8.5%

Rentabilidad vs. Industria: Los resultados de UPH fueron inferiores a los de la industria German Healthcare, que obtuvo un rendimiento del 16.5% el año pasado.

Rentabilidad vs. Mercado: UPH superó al mercado German, que obtuvo un rendimiento del 8.5% el año pasado.

Volatilidad de los precios

Is UPH's price volatile compared to industry and market?
UPH volatility
UPH Average Weekly Movement	5.5%
Healthcare Industry Average Movement	4.1%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.3%

Precio estable de las acciones: UPH no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de UPH (6%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1990	5,310	Chris Reading	www.usph.com

U.S. Physical Therapy, Inc. gestiona clínicas de fisioterapia ambulatoria. La empresa opera a través de los segmentos Physical Therapy Operations e Industrial Injury Prevention Services. La empresa proporciona cuidados y tratamientos pre y postoperatorios para trastornos ortopédicos, lesiones deportivas, cuidados preventivos, rehabilitación de trabajadores lesionados y lesiones neurológicas.

Resumen de fundamentos de U.S. Physical Therapy, Inc.

¿Cómo se comparan los beneficios e ingresos de U.S. Physical Therapy con su capitalización de mercado?
Estadísticas fundamentales de UPH
Capitalización bursátil	€1.42b
Beneficios(TTM)	€13.54m
Ingresos (TTM)	€613.69m

104.7x

Ratio precio-beneficio (PE)

2.3x

Ratio precio-ventas (PS)

¿Está UPH sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de UPH
Ingresos	US$639.06m
Coste de los ingresos	US$513.20m
Beneficio bruto	US$125.86m
Otros gastos	US$111.76m
Beneficios	US$14.10m

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	0.93
Margen bruto	19.69%
Margen de beneficio neto	2.21%
Ratio deuda/patrimonio	21.2%

¿Cómo se ha desempeñado UPH a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

1.8%

Rentabilidad actual por dividendo

187%

Ratio de pagos

¿Paga UPH dividendos fiables?

Ver historial de dividendos e índices de referencia de UPH

¿Cuándo hay que comprar UPH para recibir un próximo dividendo?
fechas de dividendos de U.S. Physical Therapy
Fecha ex dividendo	Nov 15 2024
Fecha de pago de dividendos	Dec 06 2024
Días hasta ex dividendo	10 days
Días hasta la fecha de pago de dividendos	11 days

¿Paga UPH dividendos fiables?

Ver historial de dividendos e índices de referencia de UPH

Resumen de acción UPH

Recompensas

Análisis de riesgos

Competidores de U.S. Physical Therapy, Inc.

XTRA:RHK

€836.7m

XTRA:M12

€307.1m

XTRA:LIK

€99.7m

MUN:JTH

€24.4m

Historial de precios y rendimiento

Noticias y actualizaciones recientes

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

Recent updates

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

Now 21% undervalued after recent price drop

Chairman & CEO recently sold €196k worth of stock

Chief Operating Officer - East recently sold €242k worth of stock

First quarter dividend of US$0.44 announced

First quarter 2024 earnings released: EPS: US$0.54 (vs US$0.58 in 1Q 2023)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Fourth quarter dividend of US$0.44 announced

New minor risk - Profit margin trend

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022)

Now 21% undervalued

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: US$0.62 (vs US$0.72 in 3Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Chief Operating Officer - West recently sold €413k worth of stock

Second quarter 2023 earnings released: EPS: US$0.80 (vs US$0.87 in 2Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

First quarter 2023 earnings released: EPS: US$0.57 (vs US$0.67 in 1Q 2022)

Independent Director recently sold €439k worth of stock

Executive VP recently sold €87k worth of stock

Upcoming dividend of US$0.43 per share at 1.7% yield

Full year 2022 earnings released: EPS: US$2.25 (vs US$2.42 in FY 2021)

U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently sold €573k worth of stock

President recently sold €858k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million.

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice for $25 million.

Insufficient new directors

Upcoming dividend of US$0.41 per share

Chief Operating Officer - West recently sold €162k worth of stock

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: US$0.73 (vs US$0.66 in 3Q 2021)

U.S. Physical Therapy, Inc. Provides Operating Guidance for 2022

U.S. Physical Therapy, Inc. (NYSE : USPH) acquired 60% stake in Fourteen-clinic physical therapy practice for $19.3 million.

U.S. Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 03, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million.

Director recently bought €78k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million.

Independent Director recently bought €82k worth of stock